Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Meanwhile, pulmonary tuberculosis(TB) is one of the most common infective lung diseases in developing nations. The concurrence of pulmonary TB and COVID-19 can lead to poor prognosis, owing to the pre-existing lung damage caused by TB. Case presentation: We describe the imaging findings in 3 cases of COVID-19 pneumonia with co-existing pulmonary TB on HRCT thorax. The concurrence of COVID-19 and pulmonary TB can be a diagnostic dilemma. Correct diagnosis and prompt management is imperative to reduce mortality and morbidity. Hence it is pertinent for imaging departments to identify and report these distinct entities when presenting in conjunction.
【저자키워드】 Tuberculosis, COVID-19, Coronavirus disease 2019, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Case report, HRCT, ground glass opacities, Co-infection, COVID -19, CO-RADS, COVID-19 Reporting and Data System, TB, Tuberculosis, CT, Computed tomography, HRCT, High resolution computed tomography, AFB, Acid-fast bacilli, RT-PCR, Reverse transcriptase-polymerase chain reaction, ICU, Intensive care unit, GGOs, Ground glass opacities, DOTS, Directly Observed Therapy, Short-Course, CRP, C-reactive protein, WBC, White blood cell, DNA, Deoxyribonucleic acid, 【초록키워드】 COVID-19, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Pneumonia, diagnostic, Diagnosis, Lung disease, Infectious disease, management, morbidity, lung damage, Thorax, acute respiratory syndrome, poor prognosis, infective, reduce mortality, identify, caused, imperative, presenting, 【제목키워드】 COVID-19, diagnostic, pulmonary tuberculosis,